Christopher Ogden, SVP, Finance and Accounting: CytomX Therapeutics CTMX Sell · Filed 23/12/22

Trade details

Type: Insider sale
Amount: $2,746.2
Shares · price: 1,990 sh · $1.38 a share
Held after: 48,657 sh
Stock: CytomX Therapeutics CTMX
Person: Christopher OgdenSVP, Finance and Accounting
Trade date: 23/12/20
Filed: 23/12/22
Days to filing: 2 days

Sold 3.9% of holdings

Share of holding sold: 3.9%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/20~24/01/19

Christopher Ogden's recent trades

Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,953
1,624 sh
$4,953
Filed 06/17
Traded 06/15
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$124.1K
19,323 sh
$124.1K
Filed 03/19
Traded 03/17
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$28.6K
10,614 sh
$28.6K
Filed 25/06/17
Traded 25/06/16
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,841
1,641 sh
$4,841
Filed 25/06/17
Traded 25/06/13
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,131
8,551 sh
$5,131
Filed 25/03/20
Traded 25/03/18